A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-64140284 in Healthy Participants
Clinical trial NCT03180762 · TERMINATED
Trial details
- NCT number
- NCT03180762
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2017-09-25
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.